BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22084190)

  • 1. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
    Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
    Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
    Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
    AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response criteria in oncologic imaging: review of traditional and new criteria.
    Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
    Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of response evaluation criteria in solid tumour in anticancer treatment evaluation: results of a survey in the oncology community.
    Liu Y; Litière S; de Vries EG; Sargent D; Shankar L; Bogaerts J; Seymour L
    Eur J Cancer; 2014 Jan; 50(2):260-6. PubMed ID: 24239447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline.
    van Persijn van Meerten EL; Gelderblom H; Bloem JL
    Eur Radiol; 2010 Jun; 20(6):1456-67. PubMed ID: 20033179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of tumour response to cancer treatment: morphologic imaging role].
    Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
    Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual patient data analysis to assess modifications to the RECIST criteria.
    Bogaerts J; Ford R; Sargent D; Schwartz LH; Rubinstein L; Lacombe D; Eisenhauer E; Verweij J; Therasse P;
    Eur J Cancer; 2009 Jan; 45(2):248-60. PubMed ID: 19095437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)].
    Watanabe H; Okada M; Kaji Y; Satouchi M; Sato Y; Yamabe Y; Onaya H; Endo M; Sone M; Arai Y
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2495-501. PubMed ID: 20009446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic measurements of tumor response to treatment: practical approaches and limitations.
    Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Bodén K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
    Radiographics; 2008; 28(2):329-44. PubMed ID: 18349443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECIST revisited: a review of validation studies on tumour assessment.
    Therasse P; Eisenhauer EA; Verweij J
    Eur J Cancer; 2006 May; 42(8):1031-9. PubMed ID: 16616487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based radiology and the ACR Appropriateness Criteria.
    Blackmore CC; Medina LS
    J Am Coll Radiol; 2006 Jul; 3(7):505-9. PubMed ID: 17412113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative imaging in oncology patients: Part 2, oncologists' opinions and expectations at major U.S. cancer centers.
    Jaffe TA; Wickersham NW; Sullivan DC
    AJR Am J Roentgenol; 2010 Jul; 195(1):W19-30. PubMed ID: 20566776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver tumor response to therapy: role of quantitative imaging.
    Gonzalez-Guindalini FD; Botelho MP; Harmath CB; Sandrasegaran K; Miller FH; Salem R; Yaghmai V
    Radiographics; 2013 Oct; 33(6):1781-800. PubMed ID: 24108562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
    Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
    Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of response criteria for clinical trials of sarcoma treatment.
    Schuetze SM; Baker LH; Benjamin RS; Canetta R
    Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor response evaluation in oncology: current update.
    Shanbhogue AK; Karnad AB; Prasad SR
    J Comput Assist Tomogr; 2010 Jul; 34(4):479-84. PubMed ID: 20657213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New guidelines to evaluate the response to treatment "RECIST"].
    Sasaki T
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2179-84. PubMed ID: 11142160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
    Mazumdar M; Smith A; Schwartz LH
    J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiological monitoring of the treatment of solid tumors in practice.
    Ganten MK; Ganten TM; Schlemmer HP
    Rofo; 2014 May; 186(5):466-73. PubMed ID: 24563412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.